- Latest week
- 10 Jul 2026
- Close
- 17.209999
- Fair value
- 16.774038
- Next-week expectancy
- Undecided 53.19%
M1RN34 Chart Pack
Moderna, Inc.
Chart Summary
Over the latest 12 completed weeks ending 2026-07-10, M1RN34 rose 34.45%, moving from 12.80 to 17.21. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 54.59 and has improved across the 12-week window. Market Dynamics is 1.15 on the latest week. Next-week expectancy is undecided at 53.19% based on similar historical setup states.
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 17.21
- 12-Week Change
- 34.45%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 53.19%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 54.59
- Market Dynamics
- 1.15
Weekly Price
Price Action
Smart Money
Market Dynamics
Price Cycle
Next-State Map
SMI
Chart Summary
Key Points
- Week Ending
- 10 Jul 2026
- Latest Close
- 17.21
- 12-Week Change
- 34.45%
- Trend Signal
- Active
- Next-Week Expectancy
- Undecided 53.19%
- Signal Weeks
- 12 of 12
- Vs Trend Line
- Above
- Vs Fair Value
- Above
- Relative Strength
- 54.59
- Market Dynamics
- 1.15
Over the latest 12 completed weeks ending 2026-07-10, M1RN34 rose 34.45%, moving from 12.80 to 17.21. The latest weekly close is above the Trend Line and above Fair Value. Trend Signal is active on the latest week and was active in 12 of the last 12 weeks. Relative Strength is 54.59 and has improved across the 12-week window. Market Dynamics is 1.15 on the latest week. Next-week expectancy is undecided at 53.19% based on similar historical setup states.
Industry Peers
Brazil equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| R2AR34 Ultragenyx Pharmaceutical Inc. | SAO | 10 Jul 2026 | 17.08 | 18.64 | 17.08 | 17.84 | 4.45% |
| REGN34 Regeneron Pharmaceuticals, Inc. | SAO | 10 Jul 2026 | 55.49 | 58.02 | 55.47 | 56.58 | 1.96% |
| I1NC34 Incyte Corporation | SAO | 10 Jul 2026 | 296.96 | 300.30 | 296.96 | 300.30 | 1.12% |
| B1ME34 BeOne Medicines AG | SAO | 10 Jul 2026 | 59.88 | 59.88 | 59.88 | 59.88 | 0.00% |
| B1MR34 BioMarin Pharmaceutical Inc. | SAO | 10 Jul 2026 | 142.02 | 142.02 | 142.02 | 142.02 | 0.00% |
| T1CH34 Bio-Techne Corporation | SAO | 10 Jul 2026 | 12.16 | 12.21 | 11.96 | 12.16 | 0.00% |
| BIOM3 Biomm S.A. | SAO | 10 Jul 2026 | 6.27 | 6.44 | 6.07 | 6.20 | -1.12% |
| S1RP34 Sarepta Therapeutics, Inc. | SAO | 10 Jul 2026 | 5.00 | 5.20 | 4.82 | 4.87 | -2.60% |
| B1NT34 BioNTech SE | SAO | 10 Jul 2026 | 30.30 | 30.90 | 29.34 | 29.34 | -3.17% |
| A1LN34 Alnylam Pharmaceuticals, Inc. | SAO | 10 Jul 2026 | 80.96 | 97.69 | 76.20 | 76.96 | -4.94% |
| A1RG34 argenx SE | SAO | 10 Jul 2026 | 191.03 | 191.03 | 180.31 | 180.31 | -5.61% |
| VRTX34 Vertex Pharmaceuticals Incorporated | SAO | 10 Jul 2026 | 680.26 | 682.26 | 621.33 | 621.43 | -8.65% |